Zahra Talebi

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Positive Breast Cancer

Regulatory T Cells

Top Venues

Basic & clinical pharmacology & toxicology

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Evanthia T Roussos Torres, Won Jin Ho, Ludmila Danilova, Joseph A Tandurella, James Leatherman, Christine Rafie, Chenguang Wang, Adam M Brufsky, Patricia M LoRusso, Vincent Chung, Yuan Yuan, Melinda Downs, Ashley O'Connor, Sarah M Shin, Alexei Hernandez, Elizabeth L Engle, Richard Piekarz, Howard Streicher, Zahra Talebi, Michelle A Rudek, Qingfeng Zhu, Robert A Anders, Ashley Cimino-Mathews, Elana J Fertig, Elizabeth D Thompson, Vered Stearns, Caitriona Cahir
Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial. Nature cancer 5 (6) (2024)
Evanthia T Roussos Torres, Won Jin Ho, Ludmila Danilova, Joseph A Tandurella, James Leatherman, Christine Rafie, Chenguang Wang, Adam M Brufsky, Patricia M LoRusso, Vincent Chung, Yuan Yuan, Melinda Downs, Ashley O'Connor, Sarah M Shin, Alexei Hernandez, Elizabeth L Engle, Richard Piekarz, Howard Streicher, Zahra Talebi, Michelle A Rudek, Qingfeng Zhu, Robert A Anders, Ashley Cimino-Mathews, Elana J Fertig, Elizabeth D Thompson, Vered Stearns, Caitriona Cahir
Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial. Nature cancer 5 (6) (2024)
Thomas Drabison, Mike Boeckman, Yan Yang, Kevin M Huang, Peter de Bruijn, Mahesh R Nepal, Josie A Silvaroli, Anika T Chowdhury, Eric D Eisenmann, Xiaolin Cheng, Navjot Singh Pabla, Ron H J Mathijssen, Sharyn D Baker, Shuiying Hu, Alex Sparreboom, Zahra Talebi
Systematic Evaluation of Tyrosine Kinase Inhibitors as OATP1B1 Substrates Using a Competitive Counterflow Screen. Cancer research communications (2024)
Evanthia T Roussos Torres, Won Jin Ho, Ludmila Danilova, Joseph A Tandurella, James Leatherman, Christine Rafie, Chenguang Wang, Adam M Brufsky, Patricia M LoRusso, Vincent Chung, Yuan Yuan, Melinda Downs, Ashley O'Connor, Sarah M Shin, Alexei Hernandez, Elizabeth L Engle, Richard Piekarz, Howard Streicher, Zahra Talebi, Michelle A Rudek, Qingfeng Zhu, Robert A Anders, Ashley Cimino-Mathews, Elana J Fertig, Elizabeth D Thompson, Vered Stearns, Caitriona Cahir
Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial. Nature cancer 5 (6) (2024)
Evanthia T Roussos Torres, Won Jin Ho, Ludmila Danilova, Joseph A Tandurella, James Leatherman, Christine Rafie, Chenguang Wang, Adam M Brufsky, Patricia M LoRusso, Vincent Chung, Yuan Yuan, Melinda Downs, Ashley O'Connor, Sarah M Shin, Alexei Hernandez, Elizabeth L Engle, Richard Piekarz, Howard Streicher, Zahra Talebi, Michelle A Rudek, Qingfeng Zhu, Robert A Anders, Ashley Cimino-Mathews, Elana J Fertig, Elizabeth D Thompson, Vered Stearns, Caitriona Cahir
Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial. Nature cancer (2024)
Megan E Zavorka Thomas, Jae Yoon Jeon, Zahra Talebi, Daelynn R Buelow, Josie A Silvaroli, Moray J Campbell, Alex Sparreboom, Navjot Pabla, Sharyn D Baker
Gilteritinib-induced upregulation of S100A9 is mediated through BCL6 in acute myeloid leukemia. Blood advances 5 (23) (2022)
Eric D Eisenmann, Zahra Talebi, Alex Sparreboom, Sharyn D Baker
Boosting the oral bioavailability of anticancer drugs through intentional drug-drug interactions. Basic & clinical pharmacology & toxicology (2021)
Shadi Ziaie, Gholamhossein Mehralian, Zahra Talebi
Evaluation of medication reconciliation process in internal medicine wards of an academic medical center by a pharmacist: errors and risk factors. Internal and emergency medicine (2021)